Comparison
Why is Cronos Group, Inc. ?
- The company has declared positive results for the last 2 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at CAD 83.22 MM
- ROCE(HY) Highest at 6.45%
- RAW MATERIAL COST(Y) Fallen by -30.68% (YoY)
- Over the past year, while the stock has generated a return of 25.50%, its profits have fallen by -76.6%
How much should you buy?
- Overall Portfolio exposure to Cronos Group, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Cronos Group, Inc. for you?
High Risk, Medium Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at CAD 83.22 MM
Highest at 6.45%
Fallen by -30.68% (YoY
Highest at 3.68 times
Highest at CAD 73.38 MM
Highest at CAD 15.2 MM
Highest at 20.71 %
Highest at CAD 49.87 MM
Highest at CAD 44.84 MM
Highest at CAD 0.12
Highest at -74.46 %
Lowest at 2.06 times
Here's what is working for Cronos Group, Inc.
Pre-Tax Profit (CAD MM)
Net Profit (CAD MM)
Operating Cash Flows (CAD MM)
Net Sales (CAD MM)
Net Sales (CAD MM)
Operating Profit (CAD MM)
Operating Profit to Sales
Pre-Tax Profit (CAD MM)
Net Profit (CAD MM)
EPS (CAD)
Debtors Turnover Ratio
Raw Material Cost as a percentage of Sales
Here's what is not working for Cronos Group, Inc.
Debt-Equity Ratio
Inventory Turnover Ratio






